(loteprednol etabonate ophthalmic suspension) 0.2%
ALREX® (loteprednol etabonate ophthalmic suspension) 0.2% is used for the temporary relief of the signs and symptoms of seasonal allergy affecting the eye.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please click here for full Prescribing Information for ALREX®.
MTB.0215.USA.21
The website you are about to visit is not affiliated with Bausch + Lomb Incorporated. Bausch + Lomb is not responsible for the content, format, maintenance, or policies of the website you are about to enter and does not monitor non-affiliated websites for accuracy. Links to non-affiliated websites are provided as a convenience; they do not constitute an endorsement or support of any programs, products, or services associated with the website.